搜尋
Aytu Biopharma Inc
AYTU添加自選
2.230USD
+0.080+3.72%
收盤 07-31 16:00（美東）報價延遲15分鐘
23.94M總市值
虧損本益比TTM
關於 Aytu Biopharma Inc 公司
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc簡介
公司代碼AYTU
公司名稱Aytu Biopharma Inc
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
員工數量82
證券類型Ordinary Share
年結日Oct 20
公司地址7900 E. Union Avenue
城市DENVER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編80237
電話17204376580
網址https://aytubio.com/
公司代碼AYTU
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
Aytu Biopharma Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
常見問題
Aytu Biopharma Inc的前五大股東是誰？
Aytu Biopharma Inc的前五大股東如下：Mr. Jarrett T. (Josh) Disbrow
有多少機構持有Aytu Biopharma Inc(AYTU)的股份？
截至2026Q1，共有69家機構持有Aytu Biopharma Inc的股份，合計持有的股份價值約為3.87M，占公司總股份的36.10% 。與2025Q4相比，機構持股有所增加，增幅為-493525.00。
哪個業務部門對Aytu Biopharma Inc的收入貢獻最大？
在2026Q1，ADHD portfolio業務部門對Aytu Biopharma Inc的收入貢獻最大，創收13.22M，占總收入的87.15% 。